Dr Inverarity qualified in medicine in Edinburgh in 1995 and after some time post MRCP as a trainee in infectious diseases, trained in medical microbiology and virology in London, Oxford and Glasgow. In Glasgow during the early 2000s he gained experience of diagnosis and management of several heroin related Clostridial outbreaks affecting people who inject drugs including dealing with infection related deaths and post mortem infection diagnosis. While working in NHS Lanarkshire in 2010 and 2011 as a consultant microbiologist, he found himself working in the epicentre of an outbreak of anthrax in people who inject drugs gaining first hand experience of diagnosis and management of several cases including management of infection risks in the deceased when dealing with an ACDP Hazard Group 3 pathogen.

He returned to Edinburgh in 2014 as a consultant medical microbiologist and has been lead infection prevention and control doctor for NHS Lothian since 2015 and a member of the Edinburgh Infectious Diseases research collaborative. He has been involved in investigating several further outbreaks in people who inject drugs with appreciable mortality from Streptococcus pyogenes and Staphylococcus aureus (particularly from injecting ethylphenidate related psychoactive substances) with experience of advising and producing guidance for substance misuse services and police on infection recognition and management and microbiological culture of samples from forensic post mortems.

Since 2019 much of his work has involved advising on building design and commissioning of a variety of different clinical areas particularly with regards to provision of water quality and mechanical ventilation provision including to mortuary areas. Involvement in identifying design non-compliances and infection risk in the Royal Hospital for Children and Young People and Department of Clinical Neurosciences in Edinburgh resulted in being called as a witness to the Scottish Hospitals Inquiry to give evidence.

Dr Richardson is the Clinical Head of Service for the Mycology Reference Centre Manchester and a member of the Infectious Diseases team. She is an internationally recognised expert, senior researcher, educator and clinician in the field of fungal infectious diseases.  She is an academic clinician who has published over 200 peer-reviewed articles and books or book chapters in the field of medical microbiology, medical mycology, mucosal immunology, infectious diseases and oral medicine, and has an h-index of 58.

Dr Rautemaa-Richardson has special expertise in the diagnosis and management of a superficial and systemic of mycoses including those in compromised patients. She also has expertise in antimicrobial stewardship and infection prevention. She is an author of the recently updated BASHH guideline on Vulvovaginal candidiasis as well as the ECMM/ISHAM Candidiasis and Rare yeasts global guidelines. She is the Lead for Infectious Diseases learning for Manchester Medical School, the Chair of the UK SMI Bacteriology Working Group, and the lead for the ESCMID Academy. She is also the President for the British Society for Medical Mycology. She has years of editorial experience and is currently an Editor for the Journal of Antimicrobial Chemotherapy.

Dr Sadia Zafreen is a Consultant Paediatric and Perinatal Pathologist based at Aberdeen Royal Infirmary. Her practice encompasses a broad range of this speciality including paediatric oncology pathology, paediatric general surgical pathology, placental pathology, perinatal autopsy, and paediatric forensic pathology. She has a particular professional and academic interest in perinatal and paediatric autopsy pathology.